Table 4.

Tumor cells sensitive to ferroptosis.

Cancer type	Therapeutic	Type of evidence	Reference
Hepatocellular carcinoma	Erastin	Cell culture	(Dixon et al., 2012)
	Sorafenib	Cell culture; Cancer cells from patients	(Lachaier et al., 2014)
	Solasonine	Cell culture; Mice xenotransplantation model	(Jin et al., 2020)
Gastric carcinoma	Erastin	Cell culture	(Wang et al., 2016)
	Sulfasalazine(SAS)	Cell culture	(Okazaki et al., 2018)
	Buthionine sulfoximine (BSO)	Cell culture	(Wang et al., 2016)
Ovarian carcinoma	Erastin	Cell culture	(Zhou et al., 2019)
	Artesunate	Cancer cells from patients	(Greenshields et al., 2017)
Pancreatic carcinoma	Erastin	Cell culture	(Ohman et al., 2016)
	Artesunate	Cell culture	(Eling et al., 2015)
	Sorafenib	Cell culture	(Lachaier et al., 2014)
	Piperlongumine	Cell culture	(Yuki et al., 2018)
Breast carcinoma	Erastin	Cell culture	(Ma S. et al., 2017)
	Siramesine	Cell culture	(Ma S. et al., 2017)
	Lapatinib	Cell culture	(Ma S. et al., 2017)
	Sulfasalazine(SAS)	Cell culture	(Yu et al., 2019)
Colorectal carcinoma	Erastin	Cell culture; Mice xenotransplantation model	(Jiang et al., 2015b)
	Sorafenib	Cell culture	(Lachaier et al., 2014)
Melanoma	BAY 87-2243	Cell culture; Mice xenotransplantation model	(Schöckel et al., 2015)
	Sorafenib	Cell culture; Mice xenotransplantation model	(Lachaier et al., 2014)
Head and neck cancer	Artesunate	Cell culture; Mice xenotransplantation model	(Roh et al., 2017)
Kidney carcinoma	Erastin	Cell culture; Mice xenotransplantation model	(Jiang et al., 2015b)
	Sorafenib	Cell culture	(Lachaier et al., 2014)
Lung carcinoma	Sorafenib	Cell culture	(Lachaier et al., 2014)
Glioblastoma	Temozolomide	Cell culture; Mice xenotransplantation model	(Buccarelli et al., 2018)
Lymphoma	Sulfasalazine (SAS)	Cell culture; Mice xenotransplantation model	(Gout et al., 2001)
Retinoblastoma	Sorafenib	Cell culture; Mice xenotransplantation model	(Louandre et al., 2015; Krainz et al., 2016)